Whanin Pharm Co (XKRX:016580) Other Net Income (Loss) : ₩0 Mil (TTM As of Jun. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Other Net Income (Loss)?

Whanin Pharm Co's Other Net Income (Loss) for the three months ended in Jun. 2024 was ₩0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩0 Mil.

Whanin Pharm Co's quarterly Other Net Income (Loss) increased from Dec. 2023 (₩0 Mil) to Mar. 2024 (₩0 Mil) but then declined from Mar. 2024 (₩0 Mil) to Jun. 2024 (₩0 Mil).

Whanin Pharm Co Other Net Income (Loss) Historical Data

The historical data trend for Whanin Pharm Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Other Net Income (Loss) Chart

Whanin Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Whanin Pharm Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Whanin Pharm Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

Whanin Pharm Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Whanin Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200

Website

http://www.whanin.co.kr

Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co Headlines

No Headlines